Glycine and Erythema multiforme - a phase IV clinical study of FDA data

Summary:

Erythema multiforme is reported as a side effect among people who take Glycine (glycine), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Euthyrox, and have Pneumonia.

The phase IV clinical study analyzes which people have Erythema multiforme when taking Glycine. It is created by eHealthMe based on reports of 1,026 people who have side effects when taking Glycine from the FDA, and is updated regularly.

What is Glycine?

Glycine has active ingredients of glycine. eHealthMe is studying from 1,064 Glycine users. Check the latest studies of Glycine.

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 1,699 drugs and 2,922 conditions by eHealthMe. Check the latest studies of Erythema multiforme.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 07, 2026

1,026 people reported to have side effects when taking Glycine.
Among them, 43 people (4.19%) have Erythema multiforme.

Could Glycine cause Erythema multiforme?

Among these 43 people:

How long have people been on Glycine when they have Erythema multiforme? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Erythema multiforme when taking Glycine? *

  • female: 80 %
  • male: 20 %

What is the age of people who have Erythema multiforme when taking Glycine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 3.12 %
  • 40-49: 3.12 %
  • 50-59: 6.25 %
  • 60+: 87.5 %

What are other drugs people take besides Glycine? *

  1. Euthyrox: 34 people, 79.07%
  2. Paracetamol: 22 people, 51.16%
  3. Acetylsalicylic Acid: 20 people, 46.51%
  4. Fluconazole: 6 people, 13.95%
  5. Ramipril: 6 people, 13.95%
  6. Allopurinol: 6 people, 13.95%
  7. Amoxicillin: 6 people, 13.95%
  8. Betaxolol Hydrochloride: 6 people, 13.95%
  9. Diazepam: 6 people, 13.95%
  10. Ibuprofen: 6 people, 13.95%

What are other side effects people have besides Erythema multiforme? *

  1. Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 33 people, 76.74%
  2. Rashes (redness): 33 people, 76.74%
  3. Pneumonia: 33 people, 76.74%
  4. Sopor (sleep): 32 people, 74.42%
  5. Drug Ineffective: 31 people, 72.09%
  6. Depressed Level Of Consciousness: 31 people, 72.09%
  7. Cuts And Puncture Wounds: 16 people, 37.21%
  8. Thrombophlebitis Migrans (development of recurrent (i.e. migratory) superficial thrombophlebitis): 1 person, 2.33%
  9. Prostate Cancer: 1 person, 2.33%
  10. Itching: 1 person, 2.33%

What are the existing conditions these people have? *

  1. Pneumonia: 34 people, 79.07%
  2. High Blood Pressure: 33 people, 76.74%
  3. Pain: 33 people, 76.74%
  4. Partial Seizures (seizures which affect only a part of the brain at onset): 32 people, 74.42%
  5. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 32 people, 74.42%
  6. Gout (uric acid crystals building up in the body): 26 people, 60.47%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 25 people, 58.14%
  8. High Blood Cholesterol: 25 people, 58.14%
  9. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 25 people, 58.14%
  10. Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 24 people, 55.81%

* Approximation only. Some reports may have incomplete information.

Do you take Glycine and have Erythema multiforme?

- Check whether Erythema multiforme is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glycine:

Erythema multiforme treatments and more:

How severe was Erythema multiforme and when was it recovered:

Expand to all the drugs that have ingredients of glycine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glycine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Erythema multiforme:

Browse all the conditions that are associated with Erythema multiforme:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on glycine (the active ingredients of Glycine) and Glycine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: